AngioDynamics (ANGO) reported Q1 EPS of ($0.06), $0.04 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $81.5 million versus the consensus estimate of $82.58 million.
GUIDANCE:
AngioDynamics sees FY2023 EPS of $0.01-$0.06, versus the consensus of $0.02. AngioDynamics sees FY2023 revenue of $342-348 million, versus the consensus of $344 million.